Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem-Reference-Cited by-同舟云学术

Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem

Published:2024-01-30 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Abrignani Maurizio Giuseppe^ORCID,Gronda Edoardo^ORCID,Marini Marco^ORCID,Gori Mauro^ORCID,Iacoviello Massimo^ORCID,Temporelli Pier Luigi^ORCID,Benvenuto Manuela^ORCID,Binaghi Giulio^ORCID,Cesaro Arturo^ORCID,Maloberti Alessandro^ORCID,Tinti Maria Denitza^ORCID,Riccio Carmine^ORCID,Colivicchi Furio^ORCID,Grimaldi Massimo^ORCID,Gabrielli Domenico^ORCID,Oliva Fabrizio^ORCID,

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10557-024-07551-7.pdf

Reference97 articles.

1. Thomsen RW, Nicolaisen SK, Hasvold P, et al. Elevated potassium levels in patients with congestive heart failure: occurrence, risk factors, and clinical outcomes: a Danish population-based cohort study. J Am Heart Assoc. 2018;7(11): e008912. https://doi.org/10.1161/JAHA.118.008912.

2. Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21. https://doi.org/10.1159/000479802.

3. Núñez J, Bayés-Genís A, Zannad F, et al. Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation. 2018;137(13):1320–30. https://doi.org/10.1161/CIRCULATIONAHA.117.030576.

4. Ferreira JP, Rossignol P, Machu JL, et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017;19:1284–93. https://doi.org/10.1002/ejhf.90.

5. Savarese G, Carrero JJ, Pitt B, et al. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018;20:1326–34. https://doi.org/10.1002/ejhf.1182.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing crush syndrome management: the potent role of Sodium zirconium cyclosilicate in early hyperkalemia intervention and survival enhancement in a rat model;Frontiers in Pharmacology;2024-05-13